337 related articles for article (PubMed ID: 19441110)
21. Growth rates of metastatic brain tumors in nonsmall cell lung cancer.
Yoo H; Nam BH; Yang HS; Shin SH; Lee JS; Lee SH
Cancer; 2008 Sep; 113(5):1043-7. PubMed ID: 18618515
[TBL] [Abstract][Full Text] [Related]
22. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective.
Paralkar VR; Li T; Langer CJ
Clin Lung Cancer; 2008 Mar; 9(2):116-21. PubMed ID: 18501099
[TBL] [Abstract][Full Text] [Related]
23. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.
Germain F; Wai ES; Berthelet E; Truong PT; Lesperance M
Am J Clin Oncol; 2008 Dec; 31(6):561-6. PubMed ID: 19060588
[TBL] [Abstract][Full Text] [Related]
24. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
Guo S; Reddy CA; Chao ST; Suh JH; Barnett GH; Vogelbaum MA; Videtic GM
Lung Cancer; 2012 Aug; 77(2):389-93. PubMed ID: 22542706
[TBL] [Abstract][Full Text] [Related]
25. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
26. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
27. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
Ruffato A; Mattioli S; Pileri S; Daddi N; D'Ovidio F; Pilotti V; Tazzari P
Eur J Cardiothorac Surg; 2009 Mar; 35(3):463-8. PubMed ID: 19150243
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
[TBL] [Abstract][Full Text] [Related]
29. Comparison of different treatment approaches for one to two brain metastases in elderly patients.
Rades D; Pluemer A; Veninga T; Schild SE
Strahlenther Onkol; 2008 Nov; 184(11):565-71. PubMed ID: 19016014
[TBL] [Abstract][Full Text] [Related]
30. Brain metastases. Histology, multiplicity, surgery, and survival.
Nussbaum ES; Djalilian HR; Cho KH; Hall WA
Cancer; 1996 Oct; 78(8):1781-8. PubMed ID: 8859192
[TBL] [Abstract][Full Text] [Related]
31. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
[TBL] [Abstract][Full Text] [Related]
32. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
33. Growth rate of newly developed metastatic brain tumors after thoracotomy in patients with non-small cell lung cancer.
Yoo H; Jung E; Nam BH; Shin SH; Gwak HS; Kim MS; Zo JI; Lee SH
Lung Cancer; 2011 Feb; 71(2):205-8. PubMed ID: 20570390
[TBL] [Abstract][Full Text] [Related]
34. An eight-year survivor with multiple brain metastases of non-small cell lung cancer: an autopsy case.
Kawamura H; Nakayama Y; Ishikawa H; Kiyozuka M; Kitamoto Y; Hasegawa M; Hirato J; Niibe H; Hayakawa K; Nakano T
Anticancer Res; 2006; 26(1B):605-9. PubMed ID: 16739328
[TBL] [Abstract][Full Text] [Related]
35. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer.
Ilie M; Hofman V; Ortholan C; Bonnetaud C; Coëlle C; Mouroux J; Hofman P
Cancer; 2012 Mar; 118(6):1726-37. PubMed ID: 21953630
[TBL] [Abstract][Full Text] [Related]
36. The use of recursive partitioning analysis grouping in patients with brain metastases from non-small-cell lung cancer.
Gülbaş H; Erkal HS; Serin M
Jpn J Clin Oncol; 2006 Apr; 36(4):193-6. PubMed ID: 16611661
[TBL] [Abstract][Full Text] [Related]
37. Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer.
Hashizume S; Nagayasu T; Hayashi T; Hidaka S; Tsuchiya T; Tagawa T; Yamasaki N; Furukawa K; Matsumoto K; Miyazaki T
Lung Cancer; 2009 Sep; 65(3):363-70. PubMed ID: 19157635
[TBL] [Abstract][Full Text] [Related]
38. [Metastatic brain tumor in the elderly].
Kawahata N; Ohtomo E
Rinsho Shinkeigaku; 1989 Sep; 29(9):1106-9. PubMed ID: 2598535
[TBL] [Abstract][Full Text] [Related]
39. Time for reappraisal of extracranial treatment options? Synchronous brain metastases from nonsmall cell lung cancer.
Lind JS; Lagerwaard FJ; Smit EF; Postmus PE; Slotman BJ; Senan S
Cancer; 2011 Feb; 117(3):597-605. PubMed ID: 20872880
[TBL] [Abstract][Full Text] [Related]
40. [The correlation between the distant metastases and organ-specific symptoms in the patients with lung cancer].
Alpar S; Uçar N; Turgut A; Kiratli T; Dursun BA; Kurt B
Tuberk Toraks; 2004; 52(1):14-8. PubMed ID: 15143367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]